Publication | Closed Access
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
438
Citations
16
References
2020
Year
FibrosisHepatologyLiver PhysiologyClinical TrialsPathologyLiver DiseaseBridging FibrosisHepatology FibrosisMedicineCirrhosisAutoimmune Liver DiseaseHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1